We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Allergan plc | NYSE:AGN | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 193.02 | 0 | 01:00:00 |
TIDM0QCV TIDM0Y7T FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) State Street Global Advisors & Affiliates --------------------------------------------- ------------------------------- Company dealt in AbbVie Inc. --------------------------------------------- ------------------------------- Class of relevant security to which US$0.01 common stock the dealings being disclosed relate (Note 2) --------------------------------------------- ------------------------------- Date of dealing 03(rd) January 2020 --------------------------------------------- ------------------------------- 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short ------------------------------------- -------------------- ----------- Number (%) Number (%) ------------------------------------- ---------- -------- ------ --- (1) Relevant securities 68,996,430 4.66546% ------------------------------------- ---------- -------- ------ --- (2) Derivatives (other than options) N/A ------------------------------------- ---------- -------- ------ --- (3) Options and agreements to purchase/sell N/A ------------------------------------- ---------- -------- ------ --- Total 68,996,430 4.66546% ------------------------------------- ---------- -------- ------ --- (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short ------------------------------------------- ----------- ----------- Number (%) Number (%) ------------------------------------------- ------ --- ------ --- (1) Relevant securities N/A ------------------------------------------- ------ --- ------ --- (2) Derivatives (other than options) N/A ------------------------------------------- ------ --- ------ --- (3) Options and agreements to purchase/sell N/A ------------------------------------------- ------ --- ------ --- Total N/A ------------------------------------------- ------ --- ------ --- 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 5) -------------- ----------------------------- ----------------------- Purchase 48,800 89.24 -------------- ----------------------------- ----------------------- Purchase 300 88.70 -------------- ----------------------------- ----------------------- Purchase 2,200 88.70 -------------- ----------------------------- ----------------------- Purchase 13,350 88.70 -------------- ----------------------------- ----------------------- Purchase 29,760 88.70 -------------- ----------------------------- ----------------------- Purchase 2,204 88.70 -------------- ----------------------------- ----------------------- Purchase 1,632 88.70 -------------- ----------------------------- ----------------------- Purchase 594 88.70 -------------- ----------------------------- ----------------------- Purchase 9,100 88.70 -------------- ----------------------------- ----------------------- Purchase 13,900 88.70 -------------- ----------------------------- ----------------------- Purchase 46,410 88.70 -------------- ----------------------------- ----------------------- Purchase 515 88.70 -------------- ----------------------------- ----------------------- Purchase 4,380 88.70 -------------- ----------------------------- ----------------------- Purchase 524 88.16 -------------- ----------------------------- ----------------------- Purchase 1,112 88.70 -------------- ----------------------------- ----------------------- Purchase 1,112 88.70 -------------- ----------------------------- ----------------------- Purchase 257 88.70 -------------- ----------------------------- ----------------------- Purchase 559 88.70 -------------- ----------------------------- ----------------------- Sale 500 88.70 -------------- ----------------------------- ----------------------- Sale 217 88.70 -------------- ----------------------------- ----------------------- Sale 1,066 88.70 -------------- ----------------------------- ----------------------- Sale 707 88.70 -------------- ----------------------------- ----------------------- Sale 1,785 88.70 -------------- ----------------------------- ----------------------- Sale 83,660 88.70 -------------- ----------------------------- ----------------------- Sale 2,870 88.70 -------------- ----------------------------- ----------------------- (b) Derivatives transactions (other than options transactions) Product name, Nature of transaction Number of relevant securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) ------------- --------------------- ----------------------------- -------------- N/A ------------- --------------------- ----------------------------- -------------- (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money e.g. call option purchasing securities to which price American, date paid/received varying etc. the option relates European etc. per unit (Note 5) (Note 7) ----------------- ----------------- -------------------- -------- -------------- ------ ------------------ N/A ----------------- ----------------- -------------------- -------- -------------- ------ ------------------ (ii) Exercising Product name, Number of securities Exercise price per e.g. call option unit (Note 5) ----------------- -------------------- ------------------ N/A ----------------- -------------------- ------------------ (d) Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) --------------------- ------- ------------------------- N/A --------------------- ------- ------------------------- 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. ----------------------------------------------------------- N/A ----------------------------------------------------------- Is a Supplemental Form 8 attached? (Note 9) NO ------------------------------------------------------- ------------------- Date of disclosure 06(th) January 2020 ------------------------------------------------------- ------------------- Contact name Colin Fernandes ------------------------------------------------------- ------------------- Telephone number 020 33956221 ------------------------------------------------------- ------------------- If a connected EFM, name of offeree/offeror with which N/A connected ------------------------------------------------------- ------------------- If a connected EFM, state nature of connection (Note N/A 10) ------------------------------------------------------- -------------------
(END) Dow Jones Newswires
January 06, 2020 09:44 ET (14:44 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions